Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018)
Senseonics Holdings (SENS) reported Current Deferred Revenue of $628000.0 for Q4 2018, up 6877.78% on a QoQ basis from $9000.0 in Q1 2016.
Senseonics Holdings (SENS) has 3 years of Current Deferred Revenue data on file, last reported at $628000.0 in Q4 2018.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $628000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $628000.0 (changed N/A YoY) and the FY2018 annual result came in at $628000.0, changed N/A from the prior year.
- Current Deferred Revenue climbed to $628000.0 in Q4 2018 per SENS's latest filing, from $9000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $628000.0 in Q4 2018 and bottomed at $7000.0 in Q4 2015.
- The 3-year median for Current Deferred Revenue is $9000.0 (2016), against an average of $214666.7.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 628,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Dec 31, 2015 | 7,000.00 |